Literature DB >> 1360704

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

S P Cole1, G Bhardwaj, J H Gerlach, J E Mackie, C E Grant, K C Almquist, A J Stewart, E U Kurz, A M Duncan, R G Deeley.   

Abstract

The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360704     DOI: 10.1126/science.1360704

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  554 in total

1.  Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics.

Authors:  N Strazielle; J F Ghersi-Egea
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  Molecular Events as Targets of Anticancer Drug Therapy.

Authors:  Adorján Aszalós; Sándor Eckhardt
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

3.  Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy.

Authors:  P Duesberg; R Stindl; R Hehlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 4.  The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Authors:  Margaret M Doherty; William N Charman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Biology and modulation of multidrug resistance (MDR) in hematological malignancies.

Authors:  Masao Hirose
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  AtMRP1 gene of Arabidopsis encodes a glutathione S-conjugate pump: isolation and functional definition of a plant ATP-binding cassette transporter gene.

Authors:  Y P Lu; Z S Li; P A Rea
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

7.  Determinant of the extracellular location of the N-terminus of human multidrug-resistance-associated protein.

Authors:  J T Zhang
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

8.  The use of Tris-lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1.

Authors:  Ross A Davey; Mary W Davey; Karen V Cullen; Xanthe E Wells; Craig L Francis; Hua-Ming Williams; Qi Yang; Minoo J Moghaddam; Fred Widmer; Robert G Whittaker
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

9.  Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells.

Authors:  Sungpil Cho; Meiling Lu; Xiaolong He; Pui-Lai Rachel Ee; Uppoor Bhat; Erasmus Schneider; Lucio Miele; William T Beck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

10.  Mrp1 localization and function in cardiac mitochondria after doxorubicin.

Authors:  Paiboon Jungsuwadee; Ramaneeya Nithipongvanitch; Yumin Chen; Terry D Oberley; D Allan Butterfield; Daret K St Clair; Mary Vore
Journal:  Mol Pharmacol       Date:  2009-02-20       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.